home / stock / clsn / clsn quote
Last: | $1.96 |
---|---|
Change Percent: | 0.0% |
Open: | $1.96 |
Close: | $1.96 |
High: | $1.9999 |
Low: | $1.9286 |
Volume: | 57,866 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.96 | $1.96 | $1.96 | $1.9999 | $1.9286 | 57,866 | 09-20-2022 |
$1.96 | $2.01 | $1.96 | $2.02 | $1.93 | 45,891 | 09-19-2022 |
$2.04 | $2.03 | $2.04 | $2.11 | $2.02 | 16,888 | 09-16-2022 |
$2.08 | $2.05 | $2.08 | $2.29 | $2.02 | 33,247 | 09-15-2022 |
$2.07 | $2.1 | $2.07 | $2.13 | $2.02 | 20,743 | 09-14-2022 |
$2.1 | $2.24 | $2.1 | $2.2986 | $2.07 | 36,688 | 09-13-2022 |
$2.22 | $2.23 | $2.22 | $2.2893 | $2.2 | 32,807 | 09-12-2022 |
$2.2 | $2.19 | $2.2 | $2.2 | $2.105 | 37,269 | 09-09-2022 |
$2.1466 | $2.1 | $2.1466 | $2.15 | $2.06 | 22,274 | 09-08-2022 |
$2.1 | $1.93 | $2.1 | $2.17 | $1.93 | 93,066 | 09-07-2022 |
$1.9501 | $2.05 | $1.9501 | $2.05 | $1.91 | 30,872 | 09-06-2022 |
$2.045 | $2.03 | $2.045 | $2.09 | $2.03 | 11,826 | 09-02-2022 |
$2.0895 | $2.09 | $2.0895 | $2.2 | $1.98 | 93,553 | 09-01-2022 |
$2.13 | $2.3099 | $2.13 | $2.33 | $2.13 | 34,892 | 08-31-2022 |
$2.24 | $2.29 | $2.24 | $2.3099 | $2.2 | 29,626 | 08-30-2022 |
$2.25 | $2.25 | $2.25 | $2.321 | $2.22 | 26,896 | 08-29-2022 |
$2.2699 | $2.49 | $2.2699 | $2.56 | $2.26 | 69,275 | 08-26-2022 |
$2.43 | $2.45 | $2.43 | $2.45 | $2.39 | 29,336 | 08-25-2022 |
$2.4195 | $2.4 | $2.4195 | $2.45 | $2.32 | 57,105 | 08-24-2022 |
$2.37 | $2.35 | $2.37 | $2.39 | $2.3 | 33,833 | 08-23-2022 |
News, Short Squeeze, Breakout and More Instantly...
New name reflects the evolution of the Company’s business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company, today announced ...
110 Patients Enrolled in Study Comparing Novel Gene-Mediated Immunotherapy plus Neoadjuvant Chemotherapy versus Neoadjuvant Chemotherapy Alone LAWRENCEVILLE, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage company focused on DNA-ba...
LAWRENCEVILLE, N.J., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) , a clinical-stage drug development company, announces that Dr. Corinne Le Goff, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 24 th An...